Literature DB >> 30022487

Mosaicism due to postzygotic mutations in women with focal dermal hypoplasia.

L Heinz1,2, E Bourrat3, P Vabres4, J Thevenon5,6, A Hotz1, S Hörer1,2, J Küsel1, A D Zimmer1, S Alter1, R Happle7, J Fischer1.   

Abstract

Focal dermal hypoplasia (FDH, Goltz syndrome, MIM #305600) constitutes a rare multisystem genetic disorder of the skin, skeleton, teeth and eyes with considerable variation in the clinical features. FDH is transmitted as an X-linked dominant trait and is caused by mutations in PORCN. In male children, hemizygous PORCN mutations are lethal in utero. Around 300 cases have been reported in the literature to date. About 10% of them are male patients presenting with either Klinefelter syndrome (karyotype 47, XXY) or mosaicism of a postzygotic mutation. Here we describe four cases of women with typical features of FDH, in whom a PORCN mutation was found in DNA from affected cutaneous tissue but not in DNA from peripheral blood. This study suggests that mosaicism caused by a postzygotic mutation occurs more often than assumed to date in female patients with FDH. A negative analysis performed on peripheral blood DNA does not exclude the diagnosis of FDH and it is therefore of practical importance to analyse DNA from the affected skin in order to identify low-level mosaicism and thus to improve diagnostic precision. In total, we found two missense variants, one novel indel and one novel splice-site variant. Individuals harbouring postzygotic mosaicism run a risk of transmitting the disorder to their daughters, because the maternal mosaic could also affect the gonads.
© 2018 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30022487     DOI: 10.1111/bjd.17024

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  1 in total

1.  Life-long Skin Eruptions along Blaschko's Lines in a 27-year-old Woman: A Quiz.

Authors:  Takahiro Hamada; Kwesi Teye; Eri Katayama; Miyuki Kawamura; Hiroshi Koga; Norito Ishii; Takekuni Nakama
Journal:  Acta Derm Venereol       Date:  2021-12-07       Impact factor: 3.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.